Find Federal Grants
Communities REsilient to DIsinformation Building Local Engagement (CREDIBLE) Addendum to APS 7200AA20APS00007 Youth Power 2
Agency for International Development · 7200AA21RFA00016
Liberia USAID-Monrovia · USAIDRFI66903302021
Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)
National Institutes of Health · RFA-AI-21-023
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health · PAR-21-162
Brookwood Sago Grant
Mine Safety and Health Administration · FOA-BS-2021-1
Mine Health and Safety Grants
Mine Safety and Health Administration · MSHA-2021-1
Office of Postsecondary Education (OPE): Fund for the Improvement of Postsecondary Education (FIPSE): Supplemental Assistance to Institutions of Higher Education (SAIHE) Assistance Listing Number (ALN) 84.425S
Department of Education · ED-GRANTS-032921-001
Grant Opportunities for Leading Business Communication in English Program in Northern Japan
U.S. Mission to Japan · PAS-SAPPORO-FY2022-0001
U.S. Mission to Sudan · PAUPDFY21006
U.S. Mission to Sudan · PAUPDFY21005
U.S. Mission to Jordan · PAS-JOR-FY21-003
Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)
National Institutes of Health · RFA-TW-21-001
Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)
National Institutes of Health · RFA-TW-21-002
U.S. Mission to India · M-NOFO-21-103
National Institutes of Health · PAR-21-208
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-21-206
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-166
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
National Institutes of Health · RFA-CA-21-036
NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)
National Institutes of Health · RFA-LM-21-001
Bureau of Intelligence and Research · SFOP0007881